Prevention of Contrast Induced Nephropathy by Erythropoietin
NCT01364402
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
142
Enrollment
OTHER_GOV
Sponsor class
Conditions
Diabetes
Chronic Kidney Insufficiency
Interventions
DRUG:
Epoetin beta
DRUG:
Saline 0.9%
Sponsor
Western Galilee Hospital-Nahariya